| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
collagen type II alpha 1 chain | 0.444 | 0.846 | 1.00 |
|
disease | 0.500 | None | 0.941 | 2 | 0 | 1993 | 2020 | ||||||||
|
cartilage oligomeric matrix protein | 0.503 | 0.808 | 1.3E-09 |
|
disease | 0.500 | None | 0.971 | 2 | 0 | 1995 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2000 | 2020 | ||||||||
|
matrilin 3 | 0.644 | 0.385 | 1.4E-08 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.400 | None | 0.997 | 5 | 0 | 1992 | 2020 | ||||||||
|
asporin | 0.636 | 0.500 | 1.0E-07 |
|
disease | 0.400 | None | 0.931 | 4 | 0 | 2005 | 2019 | ||||||||
|
growth differentiation factor 5 | 0.511 | 0.692 | 0.67 |
|
disease | 0.400 | None | 0.960 | 3 | 0 | 2007 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2005 | 2019 | ||||||||
|
frizzled related protein | 0.573 | 0.654 | 1.1E-03 |
|
disease | 0.400 | None | 0.923 | 2 | 0 | 1998 | 2019 | ||||||||
|
SMAD family member 3 | 0.415 | 0.923 | 0.80 |
|
disease | 0.400 | None | 0.969 | 1 | 0 | 2003 | 2019 | ||||||||
|
S100 calcium binding protein A4 | 0.448 | 0.769 | 6.2E-03 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2006 | 2007 | ||||||||
|
bone morphogenetic protein 4 | 0.422 | 0.808 | 0.96 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
matrix metallopeptidase 13 | 0.452 | 0.923 | 7.9E-18 |
|
disease | 0.200 | None | 0.983 | 6 | 0 | 1996 | 2020 | ||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
disease | 0.200 | None | 0.900 | 1 | 0 | 1998 | 2018 | ||||||||
|
aggrecan | 0.528 | 0.846 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
cellular communication network factor 6 | 0.568 | 0.731 | 6.2E-04 |
|
disease | 0.120 | None | 1.000 | 1 | 0 | 2004 | 2015 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 5 | 0.597 | 0.654 | 8.0E-07 |
|
disease | 0.100 | None | 0.962 | 4 | 0 | 2002 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 1990 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.100 | None | 0.989 | 3 | 0 | 1989 | 2020 | ||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
disease | 0.100 | None | 0.975 | 3 | 0 | 1996 | 2019 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 4 | 0.582 | 0.692 | 2.0E-06 |
|
disease | 0.100 | None | 0.971 | 3 | 0 | 2002 | 2020 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 2003 | 2019 | ||||||||
|
TNF superfamily member 11 | 0.453 | 0.846 | 4.9E-03 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 2000 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
disease | 0.100 | None | 0.955 | 2 | 0 | 2002 | 2019 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
disease | 0.100 | None | 0.923 | 1 | 0 | 2005 | 2019 |